Lichen simplex chronicus


Key articles

Lotti T, Buggaiani G, Prignano F. Prurigo nodularis and lichen simplex chronicus. Dermatol Ther. 2008;21:42-46.Full text  Abstract

Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8-19. Abstract

Lebwohl MG, Heymann WR, Berth-Jones J, et al, eds. Treatment of skin disease: comprehensive therapeutic strategies, 2nd ed. Philadelphia, PA: Mosby/Elsevier; 2006.

Reference articles

1. Lotti T, Buggaiani G, Prignano F. Prurigo nodularis and lichen simplex chronicus. Dermatol Ther. 2008;21:42-46.Full text  Abstract

2. Lynch PJ. Lichen simplex chronicus (atopic/neurodermatitis) of the anogenital region. Dermatol Ther. 2004;17:8-19. Abstract

3. Munro DD. Disease of the skin: treatment of scalp disorders. Br Med J. 1974;1:236-238.Full text  Abstract

4. Zuccati G, Lotti T, Mastrolorenzo A, et al. Pruritus ani. Dermatol Ther. 2005;18:355-362. Abstract

5. Hashimoto K, Ito K, Kumakiri M, et al. Nylon brush macular amyloidosis. Arch Dermatol. 1987;123:633-637. Abstract

6. Weyers W, Weyers I, Bonczkowitz M, et al. Lichen amyloidosis: a consequence of scratching. J Am Acad Dermatol. 1997;37:923-928. Abstract

7. Primary Care Dermatology Society. Lichen simplex (syn. circumscribed neurodermatitis). Mar 2019 [internet publication].Full text

8. Liao YH, Lin CC, Tsai PP, et al. Increased risk of lichen simplex chronicus in people with anxiety disorder: a nationwide population-based retrospective cohort study. Br J Dermatol. 2014;170:890-894. Abstract

9. Andrianova VN, Dosychev EA. [The sensitivity of the skin to heat and pain in eczema and neurodermatitis]. Vestn Dermatol Venereol. 1966;40:13-19. Abstract

10. Cowan MA. Neurohistological changes in lichen simplex chronicus. Arch Dermatol. 1964;89:562-568. Abstract

11. Konuk N, Koca R, Atik L, et al. Psychopathology, depression and dissociative experiences in patients with lichen simplex chronicus. Gen Hosp Psychiatry. 2007;29:232-235. Abstract

12. Krishnan A, Koo J. Psyche, opioids, and itch: therapeutic consequences. Dermatol Ther. 2005;18:312-322. Abstract

13. Koo JY, Do JH, Lee CS. Psychodermatology. J Am Acad Dermatol. 2000;43:848-853. Abstract

14. James WD, Berger TG, Elston DM. Andrews' diseases of the skin: clinical dermatology, 10th ed. Philadelphia, PA:. Elsevier; 2006.

15. Virgili A, Bacilieri S, Corazza M. Evaluation of contact sensitization in vulvar lichen simplex chronicus. A proposal for a battery of selected allergens. J Reprod Med. 2003;48:33-36. Abstract

16. Crone AM, Stewart EJ, Wojnarowska F, et al. Aetiological factors in vulvar dermatitis. J Eur Acad Dermatol Venereol. 2000;14:181-186. Abstract

17. Williams HC. On the definition and epidemiology of atopic dermatitis. Dermatol Clin. 1995;13:649-657. Abstract

18. Aoki T, Kushimoto H, Hishikawa Y, et al. Nocturnal scratching and its relationship to the disturbed sleep of itchy subjects. Clin Exper Dermatol. 1991;16:268-272. Abstract

19. Bhatia MS, Gautam RK, Bedi GK. Psychiatric profile of patients with neurodermatitis. J Indian Med Assoc. 1996;94:445-446, 454. Abstract

20. Laniosz V, Wetter DA, Godar DA. Dermatologic manifestations of fibromyalgia. Clin Rheumatol. 2014;33:1009-1013. Abstract

21. Jerajani HR, Melkote S. Thin-layer rapid-use epicutaneous test (TRUE test). Indian J Dermatol Venereol Leprol. 2007;73:292-295.Full text  Abstract

22. Marks JG, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol. 1998;38:911-918. Abstract

23. Lousbergh D, Buntinx F, Pierard G. Diagnosing dermatomycosis in general practice. Fam Pract. 1999;16:611-615.Full text  Abstract

24. Robert R, Pihet M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia. 2008;166:295-306. Abstract

25. Creswell CH, Stratman EJ. Scabies: a hypersensitive subject. Clin Med Res. 2007;5:17.Full text  Abstract

26. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20:268-279.Full text  Abstract

27. van der Meijden WI, Boffa MJ, Ter Harmsel WA, et al. 2016 European guideline for the management of vulval conditions. J Eur Acad Dermatol Venereol. 2017 Feb 6;31(6):925-41.Full text  Abstract

28. Datz B, Yawalkar S. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. 1991;25:1157-1160. Abstract

29. Guzzo CA, Weiss JS, Mogavero HS, et al. A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. J Am Acad Dermatol. 1991;25:1179-1183. Abstract

30. Brunner N, Yawalkar S. A double-blind, multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus. J Am Acad Dermatol. 1991;25:1160-1163. Abstract

31. Aschoff R, Wozel G. Topical tacrolimus for the treatment of lichen simplex chronicus. J Dermatolog Treat. 2007;18:115-117. Abstract

32. Goldstein AT, Parneix-Spake A, McCormick CL, et al. Pimecrolimus cream 1% for treatment of vulvar lichen simplex chronicus: an open-label, preliminary trial. Gynecol Obstet Invest. 2007;64:180-186. Abstract

33. Tan ES, Tan AS, Tey HL. Effective treatment of scrotal lichen simplex chronicus with 0.1% tacrolimus ointment: an observational study. J Eur Acad Dermatol Venereol. 2015;29:1448-1449. Abstract

34. Vasistha LK, Singh G. Neurodermatitis and intralesional steroids. Dermatologica. 1978;157:126-128. Abstract

35. Shah CF, Pandit DM. Local infiltration of triamcinolone acetonide suspension in various skin conditions. Indian J Dermatol Venereol. 1971;37:231-234.

36. Lebwohl MG, Heymann WR, Berth-Jones J, et al, eds. Treatment of skin disease: comprehensive therapeutic strategies, 2nd ed. Philadelphia, PA: Mosby/Elsevier; 2006.

37. Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Derm Venereol. 1992;72(1):69-71. Abstract

38. Bard JW. Flurandrenolone tape in the treatment of lichen simplex chronicus. J Ky Med Assoc. 1969;67:668-670. Abstract

39. Chernosky ME, Knox JM. Atrophic striae after occlusive corticosteroid therapy. Arch Dermatol. 1964;90:15-19. Abstract

40. Corazza M, Borghi A, Minghetti S, et al. Effectiveness of silk fabric underwear as an adjuvant tool in the management of vulvar lichen simplex chronicus: results of a double-blind randomized controlled trial. Menopause. 2015 Jan 20 [Epub ahead of print]. Abstract

41. Greaves MW. Recent advances in pathophysiology and current management of itch. Ann Acad Med Singapore. 2007;36:788-792.Full text  Abstract

42. Koo JY. Treating compulsive behaviors in dermatology. West J Med. 1991;155:523.Full text  Abstract

43. Lee CS, Accordino R, Howard J, et al. Psychopharmacology in dermatology. Dermatol Ther. 2008;21:69-82.Full text  Abstract

44. Shenefelt PD. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: is it all in your mind? Dermatol Ther. 2003;16:114-122. Abstract

45. Rosenbaum MS, Ayllon T. The behavioral treatment of neurodermatitis through habit-reversal. Behav Res Ther. 1981;19:313-318. Abstract

46. Lehman RE. Brief hypnotherapy of neurodermatitis: a case with 4-year followup. Am J Clin Hypn. 1978;21:48-51. Abstract

47. Harris BA, Sherertz EF, Flowers FP. Improvement of chronic neurotic excoriations with oral doxepin therapy. Int J Dermatol. 1987;26:541-543. Abstract

48. Langley RG, Luger TA, Cork MJ, et al. An update on the safety and tolerability of pimecrolimus cream 1%: evidence from clinical trials and post-marketing surveillance. Dermatology. 2007;215(suppl 1):27-44. Abstract

49. Tupker RA, Coenraads PJ, van der Meer JB. Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol. 1992;72:463. Abstract

50. Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol. 1995;131:1403-1408. Abstract

51. Taylor JS, Praditsuwan P, Handel D, et al. Allergic contact dermatitis from doxepin cream. One-year patch test clinic experience. Arch Dermatol. 1996;132:515-518. Abstract

52. McDow RA, Wester MM. Cryosurgical treatment of nodular neurodermatitis with Refrigerant 12. J Dermatol Surg Oncol. 1989;15:621-623. Abstract

53. Lynch WS, Roenigk HH Jr. Essentials for PUVA therapy. Guidelines for photochemotherapy. Cutis. 1977;20:494-501. Abstract

54. Ling TC, Clayton TH, Crawley J, et al. British Association of Dermatologists and British Photodermatology Group guidelines for the safe and effective use of psoralen-ultraviolet A therapy 2015. Br J Dermatol. 2016 Jan;174(1):24-55.Full text  Abstract

55. Porter WM, Bewely A, Dinneen M, et al. Nodular lichen simplex of the scrotum treated by surgical excision. Br J Dermatol. 2001;144:915-916. Abstract

56. Heckmann M, Heyer G, Brunner B, et al. Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study. J Am Acad Dermatol. 2002;46:617-619. Abstract

57. Yang Q. Acupuncture treatment of 139 cases of neurodermatitis. J Tradit Chin Med. 1997;17:57-58. Abstract

58. Liu JX. Treatment of 86 cases of local neurodermatitis by electro-acupuncture (with needles inserted around diseased areas). J Tradit Chin Med. 1987;7:67. Abstract

59. Gencoglan G, Inanir I, Gunduz K. Therapeutic hotline: treatment of prurigo nodularis and lichen simplex chronicus with gabapentin. Dermatol Ther. 2010;23:194-198. Abstract

60. Vaidya DC, Schwartz RA. Prurigo nodularis: a benign dermatosis derived from a persistent pruritus. Acta Dermatovenerol Croat. 2008;16:38-44. Abstract

Use of this content is subject to our disclaimer